Works by Arnan, Montserrat
Results: 33
The direct and indirect effects of COVID‐19 pandemic in a real‐life hematological setting.
- Published in:
- Cancer Reports, 2021, v. 4, n. 4, p. 1, doi. 10.1002/cnr2.1358
- By:
- Publication type:
- Article
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.
- Published in:
- Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-024-01205-5
- By:
- Publication type:
- Article
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1
- By:
- Publication type:
- Article
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1
- By:
- Publication type:
- Article
MDS-344: Pevonedistat Plus Azacitidine vs Azacitidine Alone in Higher-Risk Myelodysplastic Syndromes (MDS): Efficacy and Safety Results from Study P-2001 (NCT02610777).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S347, doi. 10.1016/S2152-2650(21)01806-1
- By:
- Publication type:
- Article
Poster: MDS-344: Pevonedistat Plus Azacitidine vs Azacitidine Alone in Higher-Risk Myelodysplastic Syndromes (MDS): Efficacy and Safety Results from Study P-2001 (NCT02610777).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S227, doi. 10.1016/S2152-2650(21)01430-0
- By:
- Publication type:
- Article
Calreticulin mutations are not present in patients with myeloproliferative chronic myelomonocytic leukemia.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Clinical features, aetiology and outcome of bacteraemic pneumonia in neutropenic cancer patients.
- Published in:
- Respirology, 2016, v. 21, n. 8, p. 1411, doi. 10.1111/resp.12848
- By:
- Publication type:
- Article
Bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2010, v. 65, n. 2, p. 333, doi. 10.1093/jac/dkp411
- By:
- Publication type:
- Article
Invasive fungal infections in AML/ MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?
- Published in:
- Mycoses, 2016, v. 59, n. 8, p. 516, doi. 10.1111/myc.12500
- By:
- Publication type:
- Article
Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0129375
- By:
- Publication type:
- Article
Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/SF3B1 mutation in terms of phenotype and prognosis.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1385987
- By:
- Publication type:
- Article
Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 5, p. 1734, doi. 10.1111/bjh.19741
- By:
- Publication type:
- Article
Germline assessment for alloHSCT candidates over 50 years: A 'Fast‐Track' screening in myeloid neoplasms.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 2, p. 503, doi. 10.1111/bjh.19460
- By:
- Publication type:
- Article
Characteristics and long‐term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 3, p. 892, doi. 10.1111/bjh.19217
- By:
- Publication type:
- Article
Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 1, p. 52, doi. 10.1111/bjh.16857
- By:
- Publication type:
- Article
Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R).
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 7, p. 614, doi. 10.1002/ajh.24732
- By:
- Publication type:
- Article
Excess mortality in the myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 2, p. 149, doi. 10.1002/ajh.24606
- By:
- Publication type:
- Article
5′‐nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate‐risk cytogenetics.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 755, doi. 10.1111/ejh.13862
- By:
- Publication type:
- Article
Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 138, doi. 10.1111/ejh.13417
- By:
- Publication type:
- Article
Arsenic trioxide-induced peripheral neuropathy: prospective clinical and neurophysiological evaluation in a cohort of patients with acute promyelocytic leukemia.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group.
- Published in:
- Leukemia & Lymphoma, 2021, v. 62, n. 12, p. 2928, doi. 10.1080/10428194.2021.1948031
- By:
- Publication type:
- Article
Dichotomization of the new revised international prognostic scoring system for a better clinical stratification of patients with myelodysplastic syndromes.
- Published in:
- Leukemia & Lymphoma, 2019, v. 60, n. 6, p. 1522, doi. 10.1080/10428194.2018.1542151
- By:
- Publication type:
- Article
Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival.
- Published in:
- Leukemia & Lymphoma, 2018, v. 59, n. 10, p. 2383, doi. 10.1080/10428194.2017.1422858
- By:
- Publication type:
- Article
Clinical usefulness of fluorescence in situ hybridization for detection of MLL rearrangements in acute myeloid leukemia.
- Published in:
- Leukemia & Lymphoma, 2015, v. 56, n. 9, p. 2706, doi. 10.3109/10428194.2014.1003053
- By:
- Publication type:
- Article
Biological basis of extensive pleiotropy between blood traits and cancer risk.
- Published in:
- Genome Medicine, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13073-024-01294-8
- By:
- Publication type:
- Article
Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease.
- Published in:
- Croatian Medical Journal, 2016, v. 57, n. 3, p. 247, doi. 10.3325/cmj.2016.57.247
- By:
- Publication type:
- Article
Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups.
- Published in:
- Cancers, 2024, v. 16, n. 23, p. 4028, doi. 10.3390/cancers16234028
- By:
- Publication type:
- Article
Mutational Profile Enables the Identification of a High-Risk Subgroup in Myelodysplastic Syndromes with Isolated Trisomy 8.
- Published in:
- Cancers, 2023, v. 15, n. 15, p. 3822, doi. 10.3390/cancers15153822
- By:
- Publication type:
- Article
DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic features.
- Published in:
- Epigenetics, 2018, v. 13, n. 1, p. 8, doi. 10.1080/15592294.2017.1405199
- By:
- Publication type:
- Article
Serum Galactomannan–Based Early Detection of Invasive Aspergillosis in Hematology Patients Receiving Effective Antimold Prophylaxis.
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. 12, p. 1696, doi. 10.1093/cid/ciu673
- By:
- Publication type:
- Article
A phase 2, multicenter, clinical trial of CPX‐351 in older patients with secondary or high‐risk acute myeloid leukemia: PETHEMA‐LAMVYX.
- Published in:
- Cancer (0008543X), 2025, v. 131, n. 1, p. 1, doi. 10.1002/cncr.35618
- By:
- Publication type:
- Article
Increase in Bloodstream Infection Due to Vancomycin-Susceptible <i>Enterococcus faecium</i> in Cancer Patients: Risk Factors, Molecular Epidemiology and Outcomes.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0074734
- By:
- Publication type:
- Article